BioCentury
ARTICLE | Clinical News

Taksta sodium fusidate: Phase III started

January 4, 2016 8:00 AM UTC

Cempra began a double-blind, placebo-controlled, U.S. Phase III trial to compare oral Taksta twice daily vs. oral Zyvox linezolid twice daily for 10 days in about 712 patients. Patients in the Taksta...